MARTINGALE ASSET MANAGEMENT L P - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 480 filers reported holding REPLIGEN CORP in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARTINGALE ASSET MANAGEMENT L P ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2021$1,079,000
-12.6%
4,070
-4.7%
0.01%
-12.5%
Q3 2021$1,235,000
+137.5%
4,270
+64.2%
0.02%
+166.7%
Q2 2021$520,000
-97.7%
2,600
-97.8%
0.01%
-97.7%
Q1 2021$22,726,000
+7.1%
116,887
+5.6%
0.26%
+8.3%
Q4 2020$21,218,000
+496.3%
110,717
+359.3%
0.24%
+460.5%
Q3 2020$3,558,000
+24.5%
24,108
+4.3%
0.04%
+26.5%
Q2 2020$2,857,00023,1060.03%
Other shareholders
REPLIGEN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders